Recent advancements in multimodality imaging, genetic testing, and novel therapies such as myosin inhibitors have significantly improved the diagnosis and management of hypertrophic cardiomyopathy.
Akita et al. (Mon,) conducted a review in Hypertrophic cardiomyopathy. Diagnosis and management strategies was evaluated. Recent advancements in multimodality imaging, genetic testing, and novel therapies such as myosin inhibitors have significantly improved the diagnosis and management of hypertrophic cardiomyopathy.